Imgenex India Profile
Key Indicators
- Authorised Capital ₹ 1.70 Cr
as on 30-07-2024
- Paid Up Capital ₹ 1.15 Cr
as on 30-07-2024
- Company Age 20 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.76 Cr
as on 30-07-2024
- Satisfied Charges ₹ 4.79 Cr
as on 30-07-2024
- Revenue -41.90%
(FY 2023)
- Profit -175.44%
(FY 2023)
- Ebitda 16.12%
(FY 2023)
- Net Worth -1.98%
(FY 2023)
- Total Assets 1.50%
(FY 2023)
About Imgenex India
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.70 Cr and a paid-up capital of Rs 1.15 Cr.
The company currently has active open charges totaling ₹3.76 Cr. The company has closed loans amounting to ₹4.79 Cr, as per Ministry of Corporate Affairs (MCA) records.
Sujay Singh, Gita Singh, Prasanta Maiti, and One other member serve as directors at the Company.
- CIN/LLPIN
U24239OR2004PTC007628
- Company No.
007628
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Jun 2004
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Cuttack
Industry
Company Details
- Location
Bhubaneswar, Orissa, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Imgenex India Private Limited offer?
Imgenex India Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Dietary Supplements, Turnkey Consultants & Solutions, Project Report Services.
Who are the key members and board of directors at Imgenex India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sujay Singh  | Director | 04-Jun-2004 | Current |
Prasanta Maiti  | Director | 24-Mar-2014 | Current |
| Gita Singh | Director | 02-Jan-2012 | Current |
| Subrat Kar | Director | 24-Mar-2014 | Current |
Financial Performance of Imgenex India.
Imgenex India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 41.9% decrease. The company also saw a substantial fall in profitability, with a 175.44% decrease in profit. The company's net worth dipped by a decrease of 1.98%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Imgenex India?
In 2023, Imgenex India had a promoter holding of 34.77% and a public holding of 65.23%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 30 Jun 2022 | ₹3.76 Cr | Open |
Others Creation Date: 13 Feb 2018 | ₹1.20 M | Satisfied |
Biotechnology Industry Research Assistance Council Creation Date: 21 Jan 2014 | ₹1.49 Cr | Satisfied |
How Many Employees Work at Imgenex India?
Imgenex India has a workforce of 31 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Imgenex India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Imgenex India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
